Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Musliner · SciRah

Researcher profile · Semantic Scholar

T. Musliner

Share profile

T. Musliner — researcher profile on SciRah

h-index: 39
Works: 88
Citations: 14K

Most-cited papers

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
C. Cannon, M. Blazing, R. Giugliano, A. McCagg +17 more
2015New England Journal of Medicine3,018 citations Open access
Semantic Scholar
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.
S. Cummings, D. Black, D. Thompson, W. Applegate +10 more
1998Journal of the American Medical Association (JAMA)2,400 citations
Semantic Scholar
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group.
D. Black, D. Thompson, D. Bauer, K. Ensrud +5 more
2000Journal of Clinical Endocrinology and Metabolism1,022 citations Open access
Semantic Scholar
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
T. Pedersen, A. Olsson, O. Faergeman, J. Kjekshus +11 more
1998Circulation662 citations Open access
Semantic Scholar
Nondenaturing polyacrylamide gradient gel electrophoresis.
Alex V. Nichols, Ronald M. Krauss, T. Musliner
1986Methods in Enzymology518 citations
Semantic Scholar
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S)
T. Miettinen, K. Pyörälä, A. Olsson, T. Musliner +5 more
1997Circulation512 citations
Semantic Scholar
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.
C. Gagné, H. Bays, S. Weiss, P. Mata +5 more
2002American Journal of Cardiology511 citations
Semantic Scholar
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S).
T. Pedersen, J. Kjekshus, K. Pyörälä, A. Olsson +4 more
1998American Journal of Cardiology475 citations
Semantic Scholar
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
S. Haffner, C. M. Alexander, T. Cook, S. Boccuzzi +4 more
1999Archives of Internal Medicine473 citations
Semantic Scholar
Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet
Suzanne K. Swan, D. Rudy, K. Lasseter, Charles F. Ryan +15 more
2000Annals of Internal Medicine346 citations
Semantic Scholar
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
J. A. de Lemos, E. Braunwald, M. Blazing, S. Murphy +113 more
2012PLoS ONE343 citations Open access
Semantic Scholar
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.
H. Bone, S. L. Greenspan, C. McKeever, Norman H. Bell +13 more
2000Journal of Clinical Endocrinology and Metabolism318 citations Open access
Semantic Scholar
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
C. Cannon, R. Giugliano, M. Blazing, R. Harrington +8 more
2008American Heart Journal306 citations
Semantic Scholar
Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia
G. Salen, K. von Bergmann, D. Lütjohann, P. Kwiterovich +5 more
2004Circulation302 citations Open access
Semantic Scholar
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group.
M. Hochberg, P. Ross, D. Black, S. Cummings +5 more
1999Arthritis & Rheumatism292 citations Open access
Semantic Scholar
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
T. Pedersen, Kåre Berg, T. Cook, O. Faergeman +10 more
1996Archives of Internal Medicine284 citations
Semantic Scholar
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.
I. Reid, G. Nicholson, R. Weinstein, D. Hosking +9 more
1996American Journal of Medicine174 citations Open access
Semantic Scholar
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
M. Blazing, R. Giugliano, C. Cannon, T. Musliner +6 more
2014American Heart Journal100 citations Open access
Semantic Scholar
An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
R. Califf, Y. Lokhnygina, C. Cannon, M. Stepanavage +7 more
2010American Heart Journal100 citations
Semantic Scholar
Lipoprotein substrates of lipoprotein lipase and hepatic triacylglycerol lipase from human post-heparin plasma.
T. Musliner, P. Herbert, M. Kingston
1979Biochimica et Biophysica Acta100 citations
Semantic Scholar
Vertebral fracture prevalence among women screened for the Fracture Intervention Trial and a simple clinical tool to screen for undiagnosed vertebral fractures. Fracture Intervention Trial Research Group.
T. Vogt, P. Ross, L. Palermo, T. Musliner +3 more
2000Mayo Clinic proceedings94 citations
Semantic Scholar
Presence of Multiple Subpopulations of Lipoproteins of Intermediate Density in Normal Subjects
T. Musliner, Christine Giotas, R. Krauss
1986Arteriosclerosis92 citations Open access
Semantic Scholar
Lipoprotein subspecies and risk of coronary disease.
T. Musliner, R. Krauss
1988Clinical Chemistry88 citations
Semantic Scholar
Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia.
D. Kusters, M. Caceres, M. Coll, C. Cuffie +10 more
2015Jornal de Pediatria76 citations Open access
Semantic Scholar
Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.
S. Lakoski, Fang Xu, G. Vega, S. Grundy +7 more
2010Journal of Clinical Endocrinology and Metabolism75 citations Open access
Semantic Scholar
Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients.
A. Dobs, Sam S. Miller, G. Neri, S. Weiss +3 more
2000Metabolism: Clinical and Experimental73 citations Open access
Semantic Scholar
Exercise, diet, or physical characteristics as determinants of HDL-levels in endurance athletes.
Paul D. Thompson, B. Lazarus, E. Cullinane, L. Henderson +3 more
1983Atherosclerosis73 citations
Semantic Scholar
Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men
T. Sudhop, M. Reber, D. Tribble, A. Sapre +5 more
2009Journal of Lipid Research66 citations Open access
Semantic Scholar
Long‐term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2‐year, open‐label extension study
D. Lütjohann, K. von Bergmann, Waheeda Sirah, Geraldine Macdonell +5 more
2008International journal of clinical practice62 citations
Semantic Scholar
Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia
G. Assmann, F. Kannenberg, D. Ramey, T. Musliner +2 more
2008Current Medical Research and Opinion61 citations
Semantic Scholar
Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
M. Davidson, J. Voogt, J. Luchoomun, J. Decaris +12 more
2013Atherosclerosis50 citations
Semantic Scholar
Striated muscle safety of ezetimibe/simvastatin (Vytorin).
M. Davidson, D. Maccubbin, M. Stepanavage, J. Strony +1 more
2006American Journal of Cardiology48 citations
Semantic Scholar
Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
T. Musliner, Michael D. Long, T. Forte, A. V. Nichols +3 more
1991Journal of Lipid Research47 citations
Semantic Scholar
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.
T. Pedersen, A. Olsson, O. Faergeman, J. Kjekshus +11 more
1997Atherosclerosis Supplements44 citations
Semantic Scholar
Radioimmunoassay of Apolipoprotein A‐II
T. Musliner, Patricia A. Garner, L. Henderson, P. Herbert
1982Arteriosclerosis44 citations Open access
Semantic Scholar
An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae
F. Lanza, H. Schwartz, B. Sahba, H. Malaty +4 more
2000American Journal of Gastroenterology43 citations
Semantic Scholar
Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
S. Swan, D. Rudy, K. Lasseter, C. F. Ryan +15 more
2000Annals of Internal Medicine42 citations
Semantic Scholar
Activation of lipoprotein lipase by native and acylated peptides of apolipoprotein C-II.
T. Musliner, P. Herbert, Eve C. Church
1979Biochimica et Biophysica Acta42 citations
Semantic Scholar
Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
D. Tribble, M. Farnier, Geraldine Macdonell, Inna Perevozskaya +3 more
2008Metabolism: Clinical and Experimental40 citations
Semantic Scholar
An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae.
F. Lanza, H. Schwartz, B. Sahba, H. Malaty +4 more
200038 citations
Semantic Scholar
The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study
F. Lanza, B. Sahba, H. Schwartz, S. Winograd +6 more
2002American Journal of Gastroenterology35 citations
Semantic Scholar
Metabolism of Human Intermediate and Very Low Density Lipoprotein Subtractions from Normal and Dysbetalipoproteinemic Plasma: In Vivo Studies in the Rat
T. Musliner, K. McVicker, Joe F. Losefa, R. Krauss
1987Arteriosclerosis35 citations Open access
Semantic Scholar
The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.
F. Lanza, B. Sahba, H. Schwartz, S. Winograd +6 more
200233 citations
Semantic Scholar
Intestinal sterol transporters and cholesterol absorption inhibition
H. Davis, A. Tershakovec, J. Tomassini, T. Musliner
2011Current Opinion in Lipidology32 citations
Semantic Scholar
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
L. Ose, R. Reyes, A. Johnson-Levonas, A. Sapre +2 more
2007Clinical Therapeutics31 citations
Semantic Scholar
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
B. Mihaylova, I. Schlackow, W. Herrington, Jingky P. Lozano-Kühne +62 more
2016American Journal of Kidney Diseases28 citations Open access
Semantic Scholar
Interactions of high density lipoproteins with very low and low density lipoproteins during lipolysis.
T. Musliner, H. J. Michenfelder, R. Krauss
1988Journal of Lipid Research27 citations Open access
Semantic Scholar
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).
M. Blazing, R. Giugliano, J. A. de Lemos, C. Cannon +10 more
2016American Heart Journal26 citations
Semantic Scholar
Immunonephelometry of apolipoprotein A-II in plasma.
M. Rosseneu, N. Vinaimont, T. Musliner, D. Bernier +2 more
1984Clinical Chemistry26 citations
Semantic Scholar
Lipoprotein lipase cofactor activity of a carboxyl-terminal peptide of apolipoprotein C-II.
T. Musliner, Eve C. Church, P. Herbert, M. Kingston +1 more
1977Proceedings of the National Academy of Sciences of the United States of America26 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Pedersen×8
Invite
T. Pedersen — researcher profile on SciRah
M. Blazing×6
Invite
M. Blazing — researcher profile on SciRah
J. Kjekshus×6
Invite
J. Kjekshus — researcher profile on SciRah
K. Pyörälä×6
Invite
K. Pyörälä — researcher profile on SciRah

×6

Invite

T. Cook — researcher profile on SciRah

Invite

H. Quan — researcher profile on SciRah

Invite

C. Cannon — researcher profile on SciRah

R. Giugliano×5

Invite

R. Giugliano — researcher profile on SciRah

E. Braunwald×5

Invite

E. Braunwald — researcher profile on SciRah

Invite

D. Thompson — researcher profile on SciRah

Invite

A. Olsson — researcher profile on SciRah

Invite

J. Tobert — researcher profile on SciRah